Literature DB >> 25483523

Pertussis.

Giovanni Gabutti1, Chiara Azzari, Paolo Bonanni, Rosa Prato, Alberto E Tozzi, Alessandro Zanetti, Gianvincenzo Zuccotti.   

Abstract

Pertussis continues to be an important public-health issue. The high immunization coverage rates achieved, mainly in industrialized countries, have certainly decreased the spread of the pathogen. However, as immunity wanes, adolescents and adults play an important role in the dynamics of the infection. The surveillance system has several limitations and the underestimation of pertussis in adolescents, young adults and adults is mainly related to the atypical clinical characteristics of cases and the lack of lab confirmation. The real epidemiological impact of pertussis is not always perceived. The unavailability of comprehensive data should not hamper the adoption of active prophylactic measures designed to avoid the impact of waning immunity against pertussis. Different immunization strategies have been suggested and/or already adopted such as immunization of newborns, pre-school and school children, adolescents, adults, healthcare workers, childcare workers, pregnant women, cocoon strategy. Prevention of pertussis requires an integrated approach and the adoption of different immunization strategies, with the objective of achieving and maintaining high coverage rates.

Entities:  

Keywords:  epidemiology; immunization strategies; pertussis; prevention; vaccination

Mesh:

Substances:

Year:  2014        PMID: 25483523      PMCID: PMC4514233          DOI: 10.4161/hv.34364

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  103 in total

1.  Pertussis: the trials and tribulations of old and new pertussis vaccines.

Authors:  J D Cherry
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

2.  Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women.

Authors:  Yenlik A Zheteyeva; Pedro L Moro; Naomi K Tepper; Sonja A Rasmussen; Faith E Barash; Natalia V Revzina; Dmitry Kissin; Paige W Lewis; Xin Yue; Penina Haber; Jerome I Tokars; Claudia Vellozzi; Karen R Broder
Journal:  Am J Obstet Gynecol       Date:  2012-05-14       Impact factor: 8.661

Review 3.  Pertussis vaccination for health care workers.

Authors:  Thomas J Sandora; Courtney A Gidengil; Grace M Lee
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.

Authors:  B A Halperin; A Morris; D Mackinnon-Cameron; J Mutch; J M Langley; S A McNeil; D Macdougall; S A Halperin
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

5.  Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.

Authors:  Lennart Gustafsson; Luc Hessel; Jann Storsaeter; Patrick Olin
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

6.  Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.

Authors:  C Mary Healy; Marcia A Rench; Carol J Baker
Journal:  Clin Infect Dis       Date:  2012-10-24       Impact factor: 9.079

7.  Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.

Authors:  Nicholas Wood; Peter McIntyre; Helen Marshall; Don Roberton
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

8.  Effectiveness of pertussis vaccines for adolescents and adults: case-control study.

Authors:  Roger Baxter; Joan Bartlett; Ali Rowhani-Rahbar; Bruce Fireman; Nicola P Klein
Journal:  BMJ       Date:  2013-07-17

9.  Bordetella pertussis strains with increased toxin production associated with pertussis resurgence.

Authors:  Frits R Mooi; Inge H M van Loo; Marjolein van Gent; Qiushui He; Marieke J Bart; Kees J Heuvelman; Sabine C de Greeff; Dimitri Diavatopoulos; Peter Teunis; Nico Nagelkerke; Jussi Mertsola
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

10.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586

View more
  23 in total

1.  Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts.

Authors:  A Orsi; C Azzari; E Bozzola; G Chiamenti; G Chirico; S Esposito; F Francia; P Lopalco; R Prato; R Russo; A Villani; E Franco
Journal:  J Prev Med Hyg       Date:  2018-06-01

2.  Why, when and for what diseases pregnant and new mothers "should" be vaccinated.

Authors:  Giovanni Gabutti; Giorgio Conforti; Alberto Tomasi; Parvanè Kuhdari; Paolo Castiglia; Rosa Prato; Silvia Memmini; Chiara Azzari; Giovanni Vitali Rosati; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

Review 3.  Pneumococcal whole-cell and protein-based vaccines: changing the paradigm.

Authors:  Michael E Pichichero
Journal:  Expert Rev Vaccines       Date:  2017-12       Impact factor: 5.217

4.  Factors Associated with Time to Appropriate Treatment in Pertussis Cases in Georgia, 2009 to 2013.

Authors:  Dana Goodenough; Ebony Thomas; Jessica Tuttle; Robert A Bednarczyk
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 5.  What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Authors:  Nicolas Burdin; Lori Kestenbaum Handy; Stanley A Plotkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

6.  Pertussis in early life: underdiagnosed, severe, and risky disease. A seven-year experience in a pediatric tertiary-care hospital.

Authors:  Chiara Di Camillo; Anna Chiara Vittucci; Livia Antilici; Claudia Ciarlitto; Giulia Linardos; Carlo Concato; Laura Lancella; Alberto Villani
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

7.  The global burden of vaccine-preventable infectious diseases in children less than 5 years of age: Implications for COVID-19 vaccination. How can we do better?

Authors:  Lawrence D Frenkel
Journal:  Allergy Asthma Proc       Date:  2021-09-01       Impact factor: 2.587

8.  The resurgence of mumps and pertussis.

Authors:  Martine Sabbe; Corinne Vandermeulen
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

Review 9.  Decennial diphtheria-tetanus adult boosters: are they really necessary?

Authors:  C Trucchi; G Zoppi
Journal:  J Prev Med Hyg       Date:  2015-06-10

10.  Prevalence and characterization of pertactin deficient Bordetella pertussis strains in Brazil, a whole-cell vaccine country.

Authors:  Daniela Leite; Carlos Henrique Camargo; Suely Sanae Kashino; Ricardo Polatto; Luciano Moura Martins; Juliana Cristina Pereira; Lucia Pawloski; Maria Lucia Tondella; Rosangela Siqueira de Oliveira; Lourdes Rehder de Andrade Vaz de Lima
Journal:  Vaccine X       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.